Health News Releases

  • Today May 21
September 18, 2015 11:30
ProZyme, Inc. and BiOptic, Inc. Sign Licensing Agreement to Develop Gly-Q System for Glycan Analysis
ProZyme, Inc., manufacturer of bioreagents for glycobiology, and BiOptic Inc. of Taiwan, manufacturer of instruments for DNA analysis by capillary gel electrophoresis (CGE), today announce an agreemen
September 17, 2015 13:15
Cell Signaling Technology Announces the Release of a First to Market IHC-Approved VISTA Antibody
Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, announced today the release of a first to market, IHC-approved, human-specific, VISTA rabbit monoclonal antibody (mAb), for u
September 17, 2015 11:20
Joe Kiani to Deliver Keynote Remarks at the Heidelberg Interdisciplinary Patient Safety Symposium
The Heidelberg University Hospital announced today that Joe Kiani, Founder of the Patient Safety Movement Foundation will deliver the keynote address at the first annual Heidelberg Interdisciplinary P
September 15, 2015 14:20
Physio-Control to Acquire HeartSine®
Physio-Control (www.physio-control.com) has reached an agreement with HeartSine Technologies (http://heartsine.com) to acquire the Northern Ireland-based automated external defibrillator (AED) manufac
September 15, 2015 14:00
Chiltern Finalizes Acquisition of Theorem Clinical Research
Chiltern (www.chiltern.com), a leading global contract research organization (CRO), has completed its acquisition of Theorem Clinical Research, strengthening its position as the largest mid-sized prov
September 15, 2015 13:40
Ranken Jordan Pediatric Bridge Hospital Upgrades Their Monitors to the Radical-7 Featuring Masimo SET® Pulse Oximetry
Masimo (www.masimo.com) (NASDAQ: MASI) today announced that Ranken Jordan Pediatric Bridge Hospital has upgraded their monitors to the Radical-7 featuring Masimo SET® pulse oximetry. This Smart New
September 15, 2015 11:40
Takeda Joins WIPO Re:Search to Accelerate R&D of New Drugs for Neglected Tropical Diseases, Malaria and TB
Takeda Pharmaceutical Company Limited (TOKYO:4502) (http://goo.gl/eX9kbP) today announced its participation in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, v
September 14, 2015 14:00
Jubilant DraxImage Signs Term Sheet with Cyclopharm for Exclusive License to Market Technegas in the United States
Jubilant DraxImage Inc. (“DraxImage”) and Cyclopharm Limited (“CYC”) are pleased to announce the signing of a term sheet, subject to satisfactory due diligence and execution of the Definitive Agreemen
September 14, 2015 10:50
VPS Healthcare’s 3rd International Oncology Conference Attracted Over 900 delegates
VPS Healthcare (www.vpshealth.com), an integrated healthcare provider, has opened its 3rd International Oncology Conference under the theme, “Navigating Cancer care by early detection and prevention.”
September 11, 2015 18:50
Merck and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015
Merck and Pfizer today announced that six abstracts on studies evaluating the potential role of programmed death-ligand 1 (PD-L1) inhibition and the safety and efficacy of the investigational cancer i
September 10, 2015 12:00
U.S. FDA Grants Priority Review to Takeda’s Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502, http://goo.gl/eX9kbP) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review status to the New Drug Application
September 09, 2015 17:55
Jean Boulle Group - US$250 Million+ Abbott Laboratories Acquisition of Tendyne Holdings Mitral Valve Company Confirms the Group’s Pedigree for Making Serial Major Discoveries from Mines to Medical technology.
Jean Boulle Medtech Ltd, a Jean Boulle Group (www.jeanboullegroup.com) medical technology company and founding investor of Tendyne Holdings, Inc. (“Tendyne”), is pleased to announce that Abbott Labora
September 09, 2015 11:00
AstraZeneca Presents Further Evidence for the Potential of AZD9291 in First-Line and Pre-Treated Non-Small Cell Lung Cancer
AstraZeneca today announced updated data on AZD9291 in first-line patients with epidermal growth factor receptor mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC) and previously-tr
September 08, 2015 22:00
Major Innovation in Poultry Vaccines: Merial Avinew™ NeO Effervescent Tablet Advances Vaccine Delivery
Merial, the animal health division of Sanofi, today announced the global launch of a significant innovation in poultry vaccination technology: an effervescent tablet vaccine for the prevention of Newc
September 08, 2015 17:50
Boehringer Ingelheim: New Data Show That More Than 50% of Patients and Carers Struggled to Cope with Challenges of Living with Lung Cancer
The Global Lung Cancer Coalition (GLCC) presented, at the 16th World Conference on Lung Cancer (WCLC) in Denver, USA, results of Lung Cancer: We’re Listening, a global campaign, supported by Boehringe
September 07, 2015 17:40
ReSound® Returns to International Consumer Electronics Show to Feature Expanded Portfolio of Smart Hearing Aids
ReSound is pleased to announce today that it has returned to IFA, the world’s largest international consumer electronics show, in Berlin, Germany, to showcase the company’s expanding portfolio of awar
September 06, 2015 21:05
Very Low Nicotine Cigarettes: A Game-Changer for the Tobacco Industry
22nd Century Group, Inc. (NYSE MKT:XXII)(http://goo.gl/7CavNZ), a world-leader in tobacco harm reduction, announced today that the Company has launched a new website, www.magiccigarettes.com, for its
September 04, 2015 13:20
GN ReSound Opens Johor Malaysia Factory and Distribution Center to Support Continued Company Growth
Today, GN ReSound®, a global leader in innovative hearing technologies, hosted an official opening ceremony for the company’s newest manufacturing and distribution facility in Kulaijaya, Johor, Malays
August 31, 2015 09:30
ESC launches new concept for driving innovation in cardiovascular research with exclusive support from Boehringer Ingelheim
The European Society of Cardiology (ESC) today announced the launch of the competitive medical research programme ‘ESC Grants for Medical Research Innovation’, exclusively supported by an independent
August 28, 2015 09:00
Asia's Largest Business Partnering Event - Biotech Industry Key Players from 30 Countries to Gather at BioJapan 2015!
BioJapan 2015 will be held for three days from October 14th (Wed) to 16th (Fri), 2015 at Pacifico Yokohama. This Smart News Release features multimedia. View the full release here: http://www.busin
August 26, 2015 21:30
Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer
Adare Pharmaceuticals, Inc., formerly Aptalis Pharmaceutical Technologies, announced today that Joseph (Joe) Del Buono has joined the Company as Vice President, Finance and Chief Financial Officer. He
August 26, 2015 13:30
Brazil’s A.C.Camargo Cancer Center Adopts Masimo SpHb for Noninvasive and Continuous Hemoglobin Monitoring
Masimo (www.masimo.co.uk) (NASDAQ: MASI) announced today that A.C.Camargo Cancer Center (Cancer Center, http://goo.gl/tHiUjA) in Sao Paulo, Brazil has installed Masimo’s noninvasive and continuous hem
August 25, 2015 17:40
FDA and EMA accept regulatory applications for Boehringer Ingelheim’s Giotrif® / Gilotrif® (afatinib) for treatment of advanced squamous cell carcinoma of the lung
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted filing applications for afatinib for the treatment of p
August 25, 2015 14:25
ReSound Announces Expanded Android Compatibility with the ReSound Smart App for Smart Hearing Aid Wearers
ReSound®, a leader in innovative hearing technologies, announced today that it has expanded the number of Android devices compatible with the ReSound portfolio of Smart Hearing™ aids via the ReSound S
August 21, 2015 18:10
Takeda Announces European Medicines Agency Acceptance of Ixazomib’s Marketing Authorization Application for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502, http://goo.gl/eX9kbP) today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for ixazomib
25 per page50 per page75 per page100 per page